Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novogen Receives R&D Tax Incentive Cash Refund 2016-03-17 10:27
Where is Asia's Biopharma Industry Heading in 2016 and Beyond? 2016-03-16 09:15
China-based Unity Biotechnology Unveils Automated Glycohemoglobin Analyzer - Abeille 2016-03-15 20:18
MEDTEC China South 2016 to Open in Shenzhen on March 16 2016-03-15 13:05
DERMALOG Provides Fingerprint Scanners for Refugee Registration in Germany 2016-03-12 03:19
3SBio's PEG-irinotecan Wins IND Approval From China FDA 2016-03-07 17:24
3SBio Inc. Announces Expansion of its Leadership Team 2016-03-04 19:03
Nanotechnology Accelerates the Evolution of Precision Medicine, Finds Frost & Sullivan 2016-03-02 03:28
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016 2016-03-01 05:16
Veritas Genetics and WorldCare Partnership First to Integrate Next Generation Whole Genome Sequencing and World-Class Medical Second Opinion Services 2016-02-24 08:00
Value Based Healthcare Transformation Spurs Innovative Opportunities for Industry Participants 2016-02-23 22:35
Aptuit and Icagen Agree to Strategic Alliance 2016-02-22 22:00
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results 2016-02-22 20:00
Micreos Secures EUR12 Million for New Products Containing Staphefekt; Alternative to Antibiotics Can Help Millions 2016-02-18 20:00
Announcing the QA-ES III Electrosurgical Analyzer for testing and ensuring the proper performance and safety of electrosurgical units 2016-02-16 06:00
Jubilant Biosys and Sanofi Deutschland GmbH Enter Into a Strategic Alliance Focusing on Metabolic Disorders Therapeutic Area 2016-01-07 22:48
Merck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing 2016-01-07 16:41
BioAtla And Sinobioway Select First Programs For Strategic Collaboration In China Market 2016-01-06 11:20
Lixte Biotechnology Holdings, Inc. Announces Exclusive Licensing Of Their Lead Anti-Cancer Compound LB-100 For Potential Treatment Of Hepatocellular Carcinoma In Asia To Taipei Medical University 2016-01-05 09:06
Increased Investment Spurs Advances in Gene Therapy 2015-12-17 22:35
1 229 230 231 232 233